|Cell line type
|Human embryonic stem cell (hESC)
|No similar lines found.
|3rd September 2022
No feedback available yet.
Login to share your feedback, experiences or results with the research community.
|Hadassah University Hospital (HAD)
|Hadassah Human Embryonic Stem Cell Research Center
|* Is the cell line readily obtainable for third parties?
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
General Donor Information
Phenotype and Disease related information (Donor)
|A disease was diagnosed.
External Databases (Donor)
|Was the embryo established purely for research purposes?
|Have both parents consented to the use of the embryo for ESC derivation?
|Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived?
|Was the consent voluntarily given?
|Has the donor been informed that participation will not directly influence their personal treatment?
|Can you provide us with a copy of the Donor Information Sheet provided to the donor?
|Do you (Depositor/Provider) hold the original Donor Consent Form?
|Alternatives to consent are available?
|Alternatives to consent
|Alternative consent approval number
|Is there other documentation provided to the donor for consenting purposes?
|Please indicate whether the data associated with the donated material has been pseudonymised or anonymised.
|Does consent explicitly allow the derivation of pluripotent stem cells?
|Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world?
|How may genetic information associated with the cell line be accessed?
|Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample?
|Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions?
|Name of accrediting authority involved?
|Hadassah Helsinki Committee
|Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells?
|Date of derivation
|Blastula with ICM and Trophoblast
|Supernumerary embryos from IVF treatment?
Other hESC source: IVF
|ZP removal technique
|Derived under xeno-free conditions?
|Derivation under GMP?
|Available as clinical grade?
Human foreskin fibroblasts
Cellfinder Ont Id: CELDA_000001419
Base medium: Knockout-DMEM
Main protein source: Knock-out serum replacement
Serum concentration: 20 %
Analysis of Undifferentiated Cells
Microbiology / Virus Screening
Karyotyping (Cell Line)
|Has the cell line karyotype been analysed?
Passage number: 37
Karyotyping method: G-Banding
Other Genotyping (Cell Line)